These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2865931)

  • 1. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.
    Farr M; Symmons DP; Bacon PA
    Ann Rheum Dis; 1985 Nov; 44(11):798-800. PubMed ID: 2865931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis.
    Caspi D; Fuchs D; Yaron M
    Ann Rheum Dis; 1992 Feb; 51(2):275-6. PubMed ID: 1347987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three week sulphasalazine syndrome.
    Brooks H; Taylor HG; Nichol FE
    Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA; McConkey B
    Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphasalazine hepatotoxicity: lack of a hypersensitivity response.
    MacGilchrist AJ; Hunter JA
    Ann Rheum Dis; 1986 Nov; 45(11):967-8. PubMed ID: 2878646
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulphasalazine: a 'new' antirheumatic drug.
    Pullar T; Capell HA
    Br J Rheumatol; 1984 Feb; 23(1):26-34. PubMed ID: 6141832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T; Hunter JA; Capell HA
    Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity.
    Aida S
    Ann Rheum Dis; 1993 Jul; 52(7):511-6. PubMed ID: 8102225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
    Walker EM; Carty JE
    Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
    Chakravarty K; Scott DG; McCann BG
    Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The source and significance of raised serum enzymes in rheumatoid arthritis.
    Thompson PW; Houghton BJ; Clifford C; Jones DD; Whitaker KB; Moss DW
    Q J Med; 1990 Aug; 76(280):869-79. PubMed ID: 1977186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis.
    Kitas GD; Farr M; Waterhouse L; Bacon PA
    Scand J Rheumatol; 1992; 21(5):220-5. PubMed ID: 1359635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.
    Borg AA; Davis MJ; Dawes PT; Shadforth MF
    Clin Rheumatol; 1994 Sep; 13(3):522-4. PubMed ID: 7835022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity associated with maprotiline therapy: case report.
    Moldawsky RJ
    J Clin Psychiatry; 1984 Apr; 45(4):178-9. PubMed ID: 6715293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine in arthritis--an old drug rediscovered.
    Taggart AJ
    Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis.
    Boyd O; Gibbs AR; Smith AP
    Br J Rheumatol; 1990 Jun; 29(3):222-4. PubMed ID: 1972634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
    Gran JT; Myklebust G
    Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.